Suchergebnisse - "Kaur, Jatinder"

PubPharm (224)

1

NOVEL SCAFFOLD OF ADENYLYL CYCLASE INHIBITORS FOR CHRONIC PAIN AND OPIOID DEPENDENCE

enthalten in: Europäisches Patentamt | 2024

von WATTS VAL J | VAN RIJN RICHARD M | FLAHERTY DANIEL PATRICK | +1

2

Nanomedicine at the Pulmonary Frontier : Immune-Centric Approaches for Respiratory Disease Treatment

enthalten in: Immunological investigations | 2024

von Kaur, J. | Sharma, A. | Passi, G. | +6

3

Modular, multi‐barcode amplicon sequencing for improved species‐level detection of fungal phytopathogens : A case study of pipeline establishment targeting the Ophiostomatales

enthalten in: Environmental DNA | 2024

von Trollip, C. | Kaur, J. | Piper, A. | +6

4

Modelling the climate change impact of mitigation (RCP 2.6) and high emission (RCP 8.5) scenarios on maize yield and possible adaptation measures in different agroclimatic zones of Punjab, India

enthalten in: Journal of the science of food and agriculture | 2023

von Kothiyal, S. | Prabhjyot-Kaur | Sandhu, S. | +1

5

Forecasting of AQI (PM2.5) for the three most polluted cities in India during COVID-19 by hybrid Daubechies discrete wavelet decomposition and autoregressive (Db-DWD-ARIMA) model

enthalten in: Environmental science and pollution research international | 2023

von Kaur, J. | Singh, S. | Parmar, K.

6

Forecasting of AQI ($ PM_{2.5} $) for the three most polluted cities in India during COVID-19 by hybrid Daubechies discrete wavelet decomposition and autoregressive (Db-DWD-ARIMA) model

enthalten in: Environmental science and pollution research | 2023

von Kaur, J. | Singh, S. | Parmar, K.

7

Assessment of Drug-Drug Interaction Risk Between Intravenous Fentanyl and the Glecaprevir/Pibrentasvir Combination Regimen in Hepatitis C Patients Using Physiologically Based Pharmacokinetic Modeling and Simulations

enthalten in: Infectious diseases and therapy | 2023

von Mukherjee, D. | Collins, M. | Dylla, D. | +6

8

Assessment of Drug–Drug Interaction Risk Between Intravenous Fentanyl and the Glecaprevir/Pibrentasvir Combination Regimen in Hepatitis C Patients Using Physiologically Based Pharmacokinetic Modeling and Simulations

enthalten in: Infectious diseases and therapy | 2023

von Mukherjee, D. | Collins, M. | Dylla, D. | +6

9

Assessment of Drug–Drug Interaction Risk Between Intravenous Fentanyl and the Glecaprevir/Pibrentasvir Combination Regimen in Hepatitis C Patients Using Physiologically Based Pharmacokinetic Modeling and Simulations

enthalten in: Infectious diseases and therapy | 2023

von Mukherjee, D. | Collins, M. | Dylla, D. | +6

10

Assessment of Drug–Drug Interaction Risk Between Intravenous Fentanyl and the Glecaprevir/Pibrentasvir Combination Regimen in Hepatitis C Patients Using Physiologically Based Pharmacokinetic Modeling and Simulations

enthalten in: Infectious diseases and therapy | 2023

von Mukherjee, D. | Collins, M. | Dylla, D. | +6

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[23]